| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.066 | 0.8 |